NLC and Australia's BioCurate announce Strategic Alliance for Commercialization of New Therapies

NLC and BioCurate Announce Collaboration to Advance Healthcare Innovation

NLC, the European Healthtech Venture Builder based in the Netherlands, and BioCurate, an independently operated joint venture between The University of Melbourne and Monash University, have signed a Memorandum of Understanding (MoU) to collaborate on development projects aimed at bringing new therapies to market.

The partnership between BioCurate and NLC leverages their complementary strengths to unlock vast potential for healthcare innovation. Both organizations share a mission to transform top-tier innovations into life-changing products or services that advance health-related science. Focusing on early-stage projects, the collaboration aims to enhance the success of current and future initiatives in their respective portfolios by improving access to critical skills and resources necessary for translating scientific discoveries into commercially viable therapies.

The Hon. John Brumby AO, Chair of the BioCurate Board, commented:

“We’re thrilled to expand BioCurate’s network of international strategic partners through this new agreement with NLC. This partnership ensures that research from Victoria’s leading academic laboratories has a better chance of becoming transformative medicines that improve lives. It also provides NLC access to the exceptional talent we have in Victoria to support the success of their portfolio projects.”

Dr. Eric Hayes, Director of Partnerships at BioCurate, added:

“NLC stood out as a natural partner for BioCurate due to its high-quality expertise and extensive reach in the European pharmaceutical market. We look forward to exploring collaborative opportunities across our combined project portfolios.”

Bert-Arjan Millenaar, CEO of NLC, stated:

“Collaborating with BioCurate, a leader in translating novel technologies into therapeutics, represents a significant advancement for NLC in the biotech sector. This partnership expands our expert network and extends our reach into the southern hemisphere. We view BioCurate as a strategic ally in our shared mission to innovate and develop novel therapies for unmet medical needs.”

About BioCurate

BioCurate is a collaborative venture dedicated to advancing Australian research and innovation globally. Formed jointly by the University of Melbourne and Monash University, with support from the Victorian State Government, BioCurate identifies promising biomedical research discoveries and manages their translation into high-quality pre-clinical candidates aimed at developing potential novel human therapeutics.

Operating in the early phases of therapeutic development, BioCurate bridges the gap between academia and industry, overcoming barriers to success and driving early decisions. With operational independence, BioCurate’s team of experts brings decades of scientific and commercial expertise, ensuring the realization of real-world potential.

For biotech-related enquiries and collaboration opportunities, please contact Lydia Kalafateli at lydia.kalafateli@nlc.health.

For media-related requests, please contact Anne Reijns at anne.reijns@nlc.health.